BackgroundLittle information is available regarding the effect of conventional radiotherapy on glioma-related seizures.MethodsIn this retrospective study, we analyzed the seizure response and outcome following conventional radiotherapy in a cohort of 43 patients with glioma (33 grade II, 10 grade III) and medically intractable epilepsy.ResultsAt 3 months after radiotherapy, seizure reduction was significant (≥50\% reduction of frequency compared with baseline) in 31/43 patients (72\%) of the whole series and in 25/33 patients (76\%) with grade II gliomas, whereas at 12 months seizure reduction was significant in 26/34 (76\%) and in 19/25 (76\%) patients, respectively. Seizure reduction was observed more often among patients displaying an objective tumor response on MRI, but patients with no change on MRI also had a significant seizure reduction. Seizure freedom (Engel class I) was achieved at 12 months in 32\% of all patients and in 38\% of patients with grade II tumors. Timing of radiotherapy and duration of seizures prior to radiotherapy were significantly associated with seizure reduction.ConclusionsThis study showed that a high proportion of patients with medically intractable epilepsy from diffuse gliomas derive a significant and durable benefit from radiotherapy in terms of epilepsy control and that this positive effect is not strictly associated with tumor shrinkage as shown on MRI. Radiotherapy at tumor progression seems as effective as early radiotherapy after surgery. Prospective studies must confirm and better characterize the response to radiotherapy.

Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study.

L. Bertero;RICARDI, Umberto;CASTIGLIONE, Anna;SOFFIETTI, Riccardo
2013

Abstract

BackgroundLittle information is available regarding the effect of conventional radiotherapy on glioma-related seizures.MethodsIn this retrospective study, we analyzed the seizure response and outcome following conventional radiotherapy in a cohort of 43 patients with glioma (33 grade II, 10 grade III) and medically intractable epilepsy.ResultsAt 3 months after radiotherapy, seizure reduction was significant (≥50\% reduction of frequency compared with baseline) in 31/43 patients (72\%) of the whole series and in 25/33 patients (76\%) with grade II gliomas, whereas at 12 months seizure reduction was significant in 26/34 (76\%) and in 19/25 (76\%) patients, respectively. Seizure reduction was observed more often among patients displaying an objective tumor response on MRI, but patients with no change on MRI also had a significant seizure reduction. Seizure freedom (Engel class I) was achieved at 12 months in 32\% of all patients and in 38\% of patients with grade II tumors. Timing of radiotherapy and duration of seizures prior to radiotherapy were significantly associated with seizure reduction.ConclusionsThis study showed that a high proportion of patients with medically intractable epilepsy from diffuse gliomas derive a significant and durable benefit from radiotherapy in terms of epilepsy control and that this positive effect is not strictly associated with tumor shrinkage as shown on MRI. Radiotherapy at tumor progression seems as effective as early radiotherapy after surgery. Prospective studies must confirm and better characterize the response to radiotherapy.
15
12
1739
1749
http://dx.doi.org/10.1093/neuonc/not109
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829585/
ependymoma, histology, progression-free survival
R. Rudà;U. Magliola;L. Bertero;E. Trevisan;C. Bosa;C. Mantovani;U. Ricardi;A. Castiglione;C. Monagheddu;R. Soffietti
File in questo prodotto:
File Dimensione Formato  
Neuro Oncol-2013-Rudà-1739-49.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 154.58 kB
Formato Adobe PDF
154.58 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/146042
Citazioni
  • ???jsp.display-item.citation.pmc??? 29
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 51
social impact